Titre (en)
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur le lymphœdème - Analysis (UK)

Index « Titre (en) » - entrée « safety »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
safe < safety < sagittal  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000030 (2017) Esther Jennifer Campbell ; Laszlo Romics [Royaume-Uni]Oncological safety and cosmetic outcomes in oncoplastic breast conservation surgery, a review of the best level of evidence literature
000051 (2017) Ke Li [République populaire de Chine] ; Zheng Zhang [République populaire de Chine] ; Ning Fei Liu [République populaire de Chine] ; Shao Qing Feng [République populaire de Chine] ; Yun Tong [République populaire de Chine] ; Ju Fang Zhang [République populaire de Chine] ; Joannis Constantinides [Royaume-Uni] ; Davide Lazzeri [Italie] ; Luca Grassetti [Italie] ; Fabio Nicoli [Royaume-Uni] ; Yi Xin Zhang [République populaire de Chine]Efficacy and safety of far infrared radiation in lymphedema treatment: clinical evaluation and laboratory analysis.
000076 (2017) M. Gatt [Malte] ; S. Willis [Royaume-Uni] ; S. Leuschner [Allemagne]A meta-analysis of the effectiveness and safety of kinesiology taping in the management of cancer-related lymphoedema.
000342 (2014) Karim Fizazi [France] ; Christophe Massard [France] ; Petri Bono [Finlande] ; Robert Jones [Royaume-Uni] ; Vesa Kataja [Finlande] ; Nicholas James [Royaume-Uni] ; Jorge A. Garcia [États-Unis] ; Andrew Protheroe [Royaume-Uni] ; Teuvo L. Tammela [Finlande] ; Tony Elliott [Royaume-Uni] ; Leena Mattila [Finlande] ; John Aspegren [Finlande] ; Annamari Vuorela [Finlande] ; Peter Langmuir [États-Unis] ; Mika Mustonen [Finlande]Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial.
000424 (2013) Yaya Ibrahim Coulibaly [Mali] ; Ilo Dicko [Mali] ; Modibo Keita [Mali] ; Mahamadou Minamba Keita [Mali] ; Moussa Doumbia [Mali] ; Adama Daou [Mali] ; Fadima Cheick Haidara [Mali] ; Moussa Hama Sankare [Mali] ; John Horton [Royaume-Uni] ; Caroline Whately-Smith [Royaume-Uni] ; Samba Ousmane Sow [Mali]A Cluster Randomized Study of The Safety of Integrated Treatment of Trachoma and Lymphatic Filariasis in Children and Adults in Sikasso, Mali
000878 (2009) Nick Sevdalis [Royaume-Uni] ; Beverley Norris ; Chris Ranger ; Sue BothwellDesigning evidence‐based patient safety interventions: the case of the UK's National Health Service hospital wristbands
000890 (2008) Khalfan A. Mohammed [Royaume-Uni] ; Hamad J. Haji ; Albis-Francesco Gabrielli [Suisse] ; Likezo Mubila [Zimbabwe] ; Gautam Biswas [Suisse] ; Lester Chitsulo [Suisse] ; Mark H. Bradley [Royaume-Uni] ; Dirk Engels [Suisse] ; Lorenzo Savioli [Suisse] ; David H. Molyneux [Royaume-Uni]Triple Co-Administration of Ivermectin, Albendazole and Praziquantel in Zanzibar: A Safety Study
000B84 (2004) William R. Wilcox ; Maryam Banikazemi ; Nathalie Guffon [France] ; Stephen Waldek [Royaume-Uni] ; Philip Lee [Royaume-Uni] ; Gabor E. Linthorst [Pays-Bas] ; Robert J. Desnick [États-Unis] ; Dominique P. Germain [France]Long-Term Safety and Efficacy of Enzyme Replacement Therapyfor Fabry Disease
000C06 (2004) T. J. Nuttall [Royaume-Uni] ; E. A. Ferguson [Royaume-Uni] ; J. D. Littlewood [Royaume-Uni] ; A. Kelly [Royaume-Uni]P‐47 Successful management of canine atopic dermatitis with a plant extract: safety profile
000C52 (2003) William H. Makunde [Tanzanie] ; Leo M. Kamugisha [Tanzanie] ; Julius J. Massaga [Tanzanie] ; Rachel W. Makunde [Tanzanie] ; Zakana X. Savael [Tanzanie] ; Juma Akida [Tanzanie] ; Fred M. Salum [Tanzanie] ; Mark J. Taylor [Royaume-Uni]Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis
000E79 (2000) J. Horton [Royaume-Uni] ; C. Witt ; E A Ottesen ; J K Lazdins ; D G Addiss ; K. Awadzi ; M J Beach ; V Y Belizario ; S K Dunyo ; M. Espinel ; J O Gyapong ; M. Hossain ; M M Ismail ; R L Jayakody ; P J Lammie ; W. Makunde ; D. Richard-Lenoble ; B. Selve ; R K Shenoy ; P E Simonsen ; C N Wamae ; M V WeerasooriyaAn analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
001341 (1993) D A Price [Royaume-Uni] ; P E Clayton ; E H Crowne ; C R RobertsSafety and efficacy of human growth hormone treatment in girls with Turner syndrome.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Title.i -k "safety" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Title.i  \
                -Sk "safety" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Title.i
   |clé=    safety
}}
Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024